Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-003-0643-z.pdf
Reference10 articles.
1. Beer HD, Longaker MT, Werner S (1997) Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol 109:132–138
2. Brouard MC, Prins C, Mach-Pascual S, Saurat JH (2001) Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology 203:57–59
3. Buchdunger E, Zimmerman J, Mett H, Meyer T, Muller M, Regenass U, Lydon NB (1995) Selective inhibition of platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci U S A 92:2558–2562
4. Ebnoether M, Stentoft J, Ford J, Buhl L, Gratwohl A (2002) Cerebral oedema as a possible complication of treatment with imatinib. Lancet 359:1751–1752
5. Friedman HZ, Arias AM, Catchatourian R, Fretzin DF (1984) Toxic epidermal necrolysis following bone marrow transplantation. Cutis 34:158–162
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04
2. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens–Johnson syndrome, and toxic epidermal necrolysis spectrum disorders;Journal of Cutaneous Pathology;2023-09-10
3. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14
4. Diverse landscape of dermatologic toxicities from small‐molecule inhibitor cancer therapy;Journal of Cutaneous Pathology;2021-10-21
5. Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review);Oncology Reports;2020-12-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3